ADAP
Adaptimmune Therapeutics
ADAP
ADAP
84 hedge funds and large institutions have $624M invested in Adaptimmune Therapeutics in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 17 closing their positions.
Holders
84
Holders Change
-3
Holders Change %
-3.45%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
28
Reduced
21
Closed
17
Calls
$982K
Puts
$1.11M
Net Calls
-$126K
Net Calls Change
-$589K